(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate

C88H91F4N27O7S4 — CID 161405464

IUPAC(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate
SMILESCCc1cc(F)cc2c1[nH]c1nc(Nc3cnc(C(=O)OC)s3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Oc3nnc(C)o3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(C(=O)OC)s3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3nnc(C)o3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12
InChIInChI=1S/C23H24FN7O2S.C23H23FN6O2S2.C21H22FN7O2.C21H22FN7OS/c1-3-10-4-12(24)6-14-17-19(28-18(10)14)29-23(27-16-8-26-21(34-16)22(32)33-2)30-20(17)31-9-11-5-13(31)7-15(11)25;1-3-10-4-12(24)6-14-17-19(27-18(10)14)28-23(34-16-8-26-21(33-16)22(31)32-2)29-20(17)30-9-11-5-13(30)7-15(11)25;2*1-3-10-4-12(22)6-14-16-18(24-17(10)14)25-20(31-21-28-27-9(2)30-21)26-19(16)29-8-11-5-13(29)7-15(11)23/h4,6,8,11,13,15H,3,5,7,9,25H2,1-2H3,(H2,27,28,29,30);4,6,8,11,13,15H,3,5,7,9,25H2,1-2H3,(H,27,28,29);2*4,6,11,13,15H,3,5,7-8,23H2,1-2H3,(H,24,25,26)/t4*11-,13-,15-/m1111/s1
InChIKeyVUTZXPJKGQKLJD-VKUBCCMLSA-N
MW1843.14 g/mol
LogP14.66
Rot. Bonds18

About (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate

(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate (PubChem CID 161405464) has the molecular formula C88H91F4N27O7S4 and a molecular weight of 1843.14 g/mol. Its IUPAC name is (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate.

Molecular Properties

Compound Name(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate
PubChem CID161405464
Molecular FormulaC88H91F4N27O7S4
Molecular Weight1843.14 g/mol
Exact Mass1841.64
IUPAC Name(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate
SMILESCCc1cc(F)cc2c1[nH]c1nc(Nc3cnc(C(=O)OC)s3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Oc3nnc(C)o3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(C(=O)OC)s3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3nnc(C)o3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12
InChIInChI=1S/C23H24FN7O2S.C23H23FN6O2S2.C21H22FN7O2.C21H22FN7OS/c1-3-10-4-12(24)6-14-17-19(28-18(10)14)29-23(27-16-8-26-21(34-16)22(32)33-2)30-20(17)31-9-11-5-13(31)7-15(11)25;1-3-10-4-12(24)6-14-17-19(27-18(10)14)28-23(34-16-8-26-21(33-16)22(31)32-2)29-20(17)30-9-11-5-13(30)7-15(11)25;2*1-3-10-4-12(22)6-14-16-18(24-17(10)14)25-20(31-21-28-27-9(2)30-21)26-19(16)29-8-11-5-13(29)7-15(11)23/h4,6,8,11,13,15H,3,5,7,9,25H2,1-2H3,(H2,27,28,29,30);4,6,8,11,13,15H,3,5,7,9,25H2,1-2H3,(H,27,28,29);2*4,6,11,13,15H,3,5,7-8,23H2,1-2H3,(H,24,25,26)/t4*11-,13-,15-/m1111/s1
InChIKeyVUTZXPJKGQKLJD-VKUBCCMLSA-N
XLogP14.66
TPSA460.80 Ų
H-Bond Donors9
H-Bond Acceptors34
Rotatable Bonds18
Heavy Atoms130
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001843.14
LogP ≤ 514.66
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1034

Analyze (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
The IUPAC name of (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate (CID 161405464) is (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate.
What is the SMILES notation for (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
The canonical SMILES for (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate is CCc1cc(F)cc2c1[nH]c1nc(Nc3cnc(C(=O)OC)s3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Oc3nnc(C)o3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3cnc(C(=O)OC)s3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.CCc1cc(F)cc2c1[nH]c1nc(Sc3nnc(C)o3)nc(N3C[C@H]4C[C@@H]3C[C@H]4N)c12.
What is the InChIKey of (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
The InChIKey is VUTZXPJKGQKLJD-VKUBCCMLSA-N. The full InChI is InChI=1S/C23H24FN7O2S.C23H23FN6O2S2.C21H22FN7O2.C21H22FN7OS/c1-3-10-4-12(24)6-14-17-19(28-18(10)14)29-23(27-16-8-26-21(34-16)22(32)33-2)30-20(17)31-9-11-5-13(31)7-15(11)25;1-3-10-4-12(24)6-14-17-19(27-18(10)14)28-23(34-16-8-26-21(33-16)22(31)32-2)29-20(17)30-9-11-5-13(30)7-15(11)25;2*1-3-10-4-12(22)6-14-16-18(24-17(10)14)25-20(31-21-28-27-9(2)30-21)26-19(16)29-8-11-5-13(29)7-15(11)23/h4,6,8,11,13,15H,3,5,7,9,25H2,1-2H3,(H2,27,28,29,30);4,6,8,11,13,15H,3,5,7,9,25H2,1-2H3,(H,27,28,29);2*4,6,11,13,15H,3,5,7-8,23H2,1-2H3,(H,24,25,26)/t4*11-,13-,15-/m1111/s1.
What are the key properties of (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate?
(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate has a molecular weight of 1843.14 g/mol, XLogP of 14.66, 18 rotatable bonds, 9 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)oxy]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;(1R,4R,5R)-2-[8-ethyl-6-fluoro-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-9H-pyrimido[4,5-b]indol-4-yl]-2-azabicyclo[2.2.1]heptan-5-amine;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]amino]-1,3-thiazole-2-carboxylate;methyl 5-[[4-[(1R,4R,5R)-5-amino-2-azabicyclo[2.2.1]heptan-2-yl]-8-ethyl-6-fluoro-9H-pyrimido[4,5-b]indol-2-yl]sulfanyl]-1,3-thiazole-2-carboxylate is sourced from PubChem (CID 161405464), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).